Zurueck zur Suche

Reporte zur Charge UT7325JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 4 NJ 2 MN 1

VAERS 1850892

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

mild
Staat
NJ
Alter
0,8
Geschlecht
M
Eingang
08.11.2021
Impfdatum
04.10.2021
Beginn
04.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Vomiting

Symptomtext

Parent called stating child was vomiting. We offered the parent to bring the child back to the office or report to the emergency room. Patient parent decided to go to the emergency room.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1715121

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

mild
Staat
NJ
Alter
2,0
Geschlecht
F
Eingang
20.09.2021
Impfdatum
19.09.2021
Beginn
19.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abnormal behaviour Chills Glassy eyes Pain in extremity Pallor Staring Unresponsive to stimuli

Symptomtext

Vaccine administered around 3:50pm - around 6:00pm, she complained of arm pain, which is standard, so I gave her Tylenol for the pain. at 6:05ish, she became verbally unresponsive, staring off into space, not focusing on me. I picked her up and gave her a sip of water, which she bubbled back out of her mouth. I was then very concerned at this point - she was very pale, but breathing normally - no fever spiked at all this entire time or leading up to the event. I then brought her upstairs and laid her down on her changing table - her eyes were almost closed and very glassy. I then went to pick her back up and her body went limp (head flopping/hanging backwards). I then called EMS -they were no help; they did not check her vitals or anything upon arrival. When they did arrive around 6:30, she started to smile and respond a little bit via facial expressions (acting shy, etc.). She did eat dinner around 7pm - ate normally. She was starting to come out of it, responding more verbally, but still not 100% herself. She then had the shivers - but still no fever. I snuggled with her in a blanket. Around 7:40pm she bounced back to her normal self. I monitored her overnight. No fever and responded when I poked and prodded her to make sure she was ok. She woke up today totally normal. I brought her in to the doctor to check her vitals and all are normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Basic vitals check on 9/20/2021 - pulseox, weight, temperature, breathing, looked into her mouth. All normal.
Aktuelle Erkrankungen
None
Vorgeschichte
Possible asthma - not diagnosed
Andere Medikamente
Daily Multi-Vitamin and Elderberry Immune support gummies
Allergien
Peanuts and previously diagnosed egg allergy; skin test was not positive for egg allergy when taken in July 2020. Doctor cleared pt. to get the vaccine (she has received it before).
Vorherige Impfungen
-

VAERS 2265767

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

gering
Staat
-
Alter
46,0
Geschlecht
U
Eingang
06.05.2022
Impfdatum
10.11.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

total time out of range is 2 days with a minimum of 9.2C and maximum of 28.3C reported with no adverse event; Initial information received on 29-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 46 years old and unknown gender patient who was administered with influenza quadrival A-B vaccine [Fluzone Qiv] which was having total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c reported with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 10-Nov-2021, the patient received a dose of suspect influenza quadrival A-B vaccine, suspension for injection (strength and formulation: unknown) (lot UT7325JA; Expiration Date: 30-Jun-2022) via unknown route in unknown administration site for prophylactic vaccination. On an unknown date it was reported that total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c reported with no adverse event (product storage error) (unknown latency). Action taken : not applicable. At time of reporting, the outcome was Unknown for the event total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c reported with no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1726744

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

gering
Staat
PA
Alter
65,0
Geschlecht
M
Eingang
23.09.2021
Impfdatum
15.09.2021
Beginn
18.09.2021
Tage bis Beginn
3,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary mass

Symptomtext

9/15/2021 Fluzone Qiv Vaccine given in right arm , 9/18/2021 Discovered Lump in right armpit , 9/23/2021 reported to health Center. Instructed to Follow up with his personal oncologist due to hx of Lymphoma x2 time , currently in remission.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary mass
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
denies
Vorgeschichte
Lymphoma x2 in remission
Andere Medikamente
losartan
Allergien
denies
Vorherige Impfungen
-

VAERS 1713135

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

gering
Staat
PA
Alter
26,0
Geschlecht
F
Eingang
18.09.2021
Impfdatum
09.01.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Maternal exposure before pregnancy

Symptomtext

patient was administered FLUZONE QUADRIVALENT before she got pregnant, with no reported adverse event; Initial information was received on 01-Sep-2021 regarding an unsolicited valid non-serious case from other health professional. This case is linked to cases 2021SA294755, 2021SA293704, and 2021SA293706(CLUSTER). This case involves a 26-year-old female patient who was vaccinated with INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] before she got pregnant (maternal exposure before pregnancy). Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The date of last menstrual period was 30-Apr-2021 The estimated due date is 04-feb-2022. It was unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) concomitant medications and family history were not provided. On 09-Jan-2021, the patient received a dose 1 of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number: UT7325JA; expiry date: 30-Jun-2022; form: suspension for injection) via intramuscular route in unknown administration site for prophylactic vaccination. It was the case of vaccine exposure before pregnancy (same day latency). It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were laboratory data/results available. At time of reporting, the outcome was unknown for the reported event. Additionally, at time of reporting, the outcome of the pregnancy was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Maternal exposure before pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1709050

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

gering
Staat
MN
Alter
6,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
17.09.2021
Beginn
17.09.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Immunisation Syringe issue

Symptomtext

WHEN FIRST INJECTION OF INFLUENZA WAS GIVEN TO PATIENT USING NEEDLE ( 25G X 1') FROM LOT: 4155460, EXPIRATION DATE-06/08 THERE WAS A MALFUNCTION AT THE HUB OF THE SYRINGE/NEEDLE CAUSING ALL OF THE INFLUENZA FUILD SPIRT OUT. sO PATIENT HAD TO BE INJECTED A SECOND TIME & THIS WENT WITHOUT INCIDENT. PATIENTS SKIN INTREGITY WAS NORMAL AT BOTH INJECTION SITES

Weitere VAERSDATA-Felder
Praegender Schweregrund
Immunisation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1692817

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

gering
Staat
PA
Alter
26,0
Geschlecht
F
Eingang
11.09.2021
Impfdatum
09.02.2021
Beginn
09.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy

Symptomtext

Pregnant woman recieved Fluzone QIV with no reported adverse event; Initial information was received on 01-Sep-2021 regarding an unsolicited valid non-serious case from other health professional. This case involves a 26-year-old pregnant female patient who was vaccinated with INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] on 09-Feb-2021 (exposure during pregnancy). Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Pregnant woman received Fluzone QIV with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date is 02-Oct-2021. It was unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) concomitant medications and family history were not provided. On 09-Feb-2021, the patient received a dose 1 of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number: UT7325JA; expiry date: 30-Jun-2022; form: suspension for injection) via intramuscular route in unknown administration site for prophylactic vaccination. It was the case of vaccine exposure during pregnancy (same day latency). It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were laboratory data/results available. At time of reporting, the outcome was unknown for the reported event. Additionally, at time of reporting, the outcome of the pregnancy was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1692814

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7325JA

gering
Staat
PA
Alter
29,0
Geschlecht
F
Eingang
11.09.2021
Impfdatum
09.01.2021
Beginn
09.01.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy

Symptomtext

Fluzone exposure during pregnancy with no adverse event; Initial information received on 01-Sep-2021 regarding an unsolicited valid non-serious case from an other health professional and consumer/non healthcare professional. This case involves a 29 years old female pregnant patient who was vaccinated with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) [exposure during pregnancy]. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported event occurred at 45 weeks of pregnancy and the patient was exposed to QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) at 45 weeks of pregnancy, during unknown pregnancy trimester for the vaccine. The date of last menstrual period was reported as 26-Feb-2020. The estimated delivery due date was 02-Oct-2021. It was unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 09-Jan-2021, the patient received first dose of suspect FLUZONE QUADRIVALENT (suspension for injection, lot UT7325JA and expiration date 30-Jun-2022) via intramuscular route in an unknown administration site for prophylactic vaccination. It was an actual medication error case due to vaccine exposure during pregnancy (same day latency). It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were laboratory data/results available. At time of reporting, the outcome was unknown for the reported event. Additionally, at time of reporting, the outcome of the pregnancy was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-